Sugoto Mukherjee

Sugoto Mukherjee

Auto-generated profile, based on publicly available information

Sugoto Mukherjee

Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, VA 22903, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in RadioGraphics
Verified
Journal Article
Closed access
BTBrian M. Trotta
Brian M. Trotta
CPClinton S. Pease
Clinton S. Pease
JRJk John Rasamny
Jk John Rasamny
PRPrashant Raghavan
Prashant Raghavan
SMSugoto Mukherjee
Sugoto Mukherjee
The imaging findings in squamous cell carcinoma (SCC) of the oral cavity and oropharynx vary widely, depending on the site of origin of the primary tumor and the extent of its involvement of other regions. Knowledge of the complex anatomy of the oral cavity and oropharynx, as well as the most common routes by which SCC spreads from various anatomic sites, allows the radiologist to accurately determine the extent of disease and help clinicians plan appropriate treatment. SCCs that originate in the oral cavity tend to behave differently than those that originate in the oropharynx, with the latter group exhibiting more aggressive growth. Furthermore, primary tumors in certain anatomic subsites within the oral cavity or oropharynx have a greater propensity to spread by direct extension along muscle, bone, or neurovascular bundles or to be disseminated along lymphatic drainage pathways to regional or distant nodes. Imaging findings of deep muscular, neurovascular, osseous, or nodal involvement are indicative of an advanced stage of disease for which management options are limited.

27 January 2014 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
SSStephen Schoeff
Stephen Schoeff
BNBrian Nicholas
Brian Nicholas
SMSugoto Mukherjee
Sugoto Mukherjee
BKBradley W. Kesser
Bradley W. Kesser

8 January 2016 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
CDChristopher R Durst
Christopher R Durst
DODavid A Ornan
David A Ornan
MRMichael A Reardon
Michael A Reardon
PMPrachi Mehndiratta
Prachi Mehndiratta
SMSugoto Mukherjee
Sugoto Mukherjee
KLKenneth C Liu
Kenneth C Liu
Background and purpose While recent literature has described the prevalence of transverse sinus stenosis in patients with idiopathic intracranial hypertension, tinnitus, and refractory headaches, it is unclear what the prevalence is in the general population. This study evaluates the prevalence of venous sinus stenosis and hypoplasia in the general patient population. Materials and methods 355 of 600 consecutive patients who underwent CT angiography of the head met the inclusion criteria. The diameters of the dural venous sinuses were recorded. Each study was evaluated by a neuroradiologist for the presence of stenoses. Univariate and multivariate statistical analyses were performed by a statistician. Results The prevalence of unilateral transverse sinus stenosis or hypoplasia in a sample of patients representing the general population was 33%, the prevalence of bilateral transverse sinus stenosis was 5%, and the prevalence of unilateral stenosis with contralateral hypoplasia was 1%. A multivariate analysis identified arachnoid granulations as a predictor of stenosis (p<0.001). Gender trended toward significance (p=0.094). Race was not a significant predictor of stenosis (p=0.745). Conclusions The prevalence of bilateral transverse sinus stenosis in the general population is not trivial. These data may be used as a reference for understanding the mechanistic role of stenoses in idiopathic intracranial hypertension, tinnitus, and refractory headaches.

1 February 2015 in Journal of Neurosurgery
Verified
Journal Article
Closed access
RSRobert M. Starke
Robert M. Starke
CPColin J. Przybylowski
Colin J. Przybylowski
MSMukherjee Sugoto
Mukherjee Sugoto
FFFrancis Fezeu
Francis Fezeu
AAAhmed J. Awad
Ahmed J. Awad
JSJason P. Sheehan
Jason P. Sheehan
OBJECT: Stereotactic radiosurgery (SRS) has become a common treatment modality for intracranial meningiomas. Skull base meningiomas greater than 8 cm3 in volume have been found to have worse outcomes following SRS. When symptomatic, patients with these tumors are often initially treated with resection. For tumors located in close proximity to eloquent structures or in patients unwilling or unable to undergo a resection, SRS may be an acceptable therapeutic approach. In this study, the authors review the SRS outcomes of skull base meningiomas greater than 8 cm3 in volume, which corresponds to a lesion with an approximate diameter of 2.5 cm. METHODS: The authors reviewed the data in a prospectively compiled database documenting the outcomes of 469 patients with skull base meningiomas treated with single-session Gamma Knife radiosurgery (GKRS). Seventy-five patients had tumors greater than 8 cm3 in volume, which was defined as a large tumor. All patients had a minimum follow-up of 6 months, but patients were included if they had a complication at any time point. Thirty patients were treated with upfront GKRS, and 45 were treated following microsurgery. Patient and tumor characteristics were assessed to determine predictors of new or worsening neurological function and tumor progression following GKRS. RESULTS: After a mean follow-up of 6.5 years (range 0.5–21 years), the tumor volume was unchanged in 37 patients (49%), decreased in 26 patients (35%), and increased in 12 patients (16%). Actuarial rates of progression-free survival at 3, 5, and 10 years were 90.3%, 88.6%, and 77.2%, respectively. Four patients had new or worsened edema following GKRS, but preexisting edema decreased in 3 patients. In Cox multivariable analysis, covariates associated with tumor progression were 1) presentation with any cranial nerve (CN) deficit from III to VI (hazard ratio [HR] 3.78, 95% CI 1.91–7.45; p < 0.001), history of radiotherapy (HR 12.06, 95% CI 2.04–71.27; p = 0.006), and tumor volume greater than 14 cm3 (HR 6.86, 95% CI 0.88–53.36; p = 0.066). In those patients with detailed clinical follow-up (n = 64), neurological function was unchanged in 37 patients (58%), improved in 16 patients (25%), and deteriorated in 11 patients (17%). In multivariate analysis, the factors predictive of new or worsening neurological function were history of surgery (OR 3.00, 95% CI 1.13–7.95; p = 0.027), presentation with any CN deficit from III to VI (OR 3.94, 95% CI 1.49–10.24; p = 0.007), and decreasing maximal dose (OR 0.76, 95% CI 0.63–0.93; p = 0.007). Tumor progression was present in 64% of patients with new or worsening neurological decline. CONCLUSIONS: Stereotactic radiosurgery affords a reasonable rate of tumor control for large skull base meningiomas and does so with a low incidence of neurological deficits. Those with a tumor less than 14 cm3 in volume and without presenting CN deficit from III to VI were more likely to have effective tumor control.

1 January 2017 in Radiologic Clinics of North America
Verified
Journal Article
Closed access
JDJoseph H. Donahue
Joseph H. Donahue
DODavid A. Ornan
David A. Ornan
SMSugoto Mukherjee
Sugoto Mukherjee

1 August 2009 in Neuroimaging Clinics Of North America
Verified
Journal Article
Closed access
PRPrashant Raghavan
Prashant Raghavan
SMSugoto Mukherjee
Sugoto Mukherjee
CPC. Douglas Phillips
C. Douglas Phillips